✦ LIBER ✦

Measures of ageing in senile dementia of Alzheimer type and in controls

✍ Scribed by Beryl Shepherd; Dr Graham J. Naylor; Anne H. W. Smith; Ann McHarg; Margaret Harper

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 273 KB
Volume: 5
Category: Article
ISSN: 0885-6230
DOI: 10.1002/gps.930050509

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Patients suffering from senile dementia of Alzheimer type, elderly patients suffering from functional psychiatric illness and younger functionally ill patients were tested using a battery of ageing measures. Although the younger group was clearly different from the older groups, there was no statistically significant difference in measures of ageing between the demented and non‐demented elderly groups.

📜 SIMILAR VOLUMES

CT study in senile dementia of Alzheimer

CT study in senile dementia of Alzheimer type

✍ Kenichi Ueyama; Hiroshi Fukuzako; Tsuyoshi Fukuzako; Yoshirou Hokazono; Kouzou T 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

We evaluated 14 patients with senile dementia of Alzheimer type (SDAT) and 15 age-matched normal elderly controls using psychological tests and computed tomography scans. The low-density rate (LDR) was used as an index of brain atrophy. SDAT patients had significantly higher scores on the Hasegawa D

Aphasia in senile dementia of the alzhei

Aphasia in senile dementia of the alzheimer type

✍ Kathy Faber-Langendoen; Dr. John C. Morris; John W. Knesevich; Emily LaBarge; J. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Total serum homocysteine in senile demen

Total serum homocysteine in senile dementia of Alzheimer type

✍ Andrew McCaddon; Gareth Davies; Peter Hudson; Stephen Tandy; Howard Cattell 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

Objective. The main hypothesis was that subtle vitamin B12 de®ciencies occur more commonly in senile dementia of Alzheimer type (SDAT) than in healthy elderly individuals, and may be revealed by elevated total serum homocysteine (tHcy). A subsidiary hypothesis was that such de®ciencies would be nutr

Milacemide: Safety assessment in senile

Milacemide: Safety assessment in senile dementia of the Alzheimer type

✍ Maurice W. Dysken; T. Daniel Fakouhi; Stacy S. Skare; Joseph Mendels; Peter LeWi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Milacemide, both an MAO-B inhibitor and a prodrug for glycine, has demonstrated cognitive enhancing effects in animal models, in cognitively intact young and elderly, and has been suggested as a potential treatment for senile dementia of the Alzheimer type (SDAT). This multicenter open-label trial e

Orofacial dyskinesia and senile dementia

Orofacial dyskinesia and senile dementia of the Alzheimer type

✍ V. O'Keane; Dr. Timothy G. Dinan 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Cerebrospinal fluid acetylcholinesterase

Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type

✍ Dr Larry Tune; Stephen Gucker; Marshal Folstein; Leslie Oshida; Joseph T. Coyle 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

Acetylcholinesterase (AChE) activity was measured in cerebrospinal fluid (CSF) samples from 36 individuals, including 12 persons with Alzheimer's disease, 12 normal controls, and 12 patients with other dementias. AChE activity also was measured in 47 normal subjects whose ages ranged from 20 to 84 t